ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,922Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 676

$1.38M Total Retail Price of All Prescriptions

Rank: 20 out of 676

496 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

42% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 14,290 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 925 500 S3 1 1
FUROSEMIDE 586 379 2 4
LEVOTHYROXINE SODIUM 535 375 3 7
PRAVASTATIN SODIUM 472 385 4 11
DONEPEZIL HCL 423 354 5 24
GABAPENTIN 417 278 6 10
OMEPRAZOLE 408 242 7 2
AMLODIPINE BESYLATE 391 309 8 3
TRAZODONE HCL 391 223 8 36
NAMENDA 389 361 10 35
SERTRALINE HCL 380 276 11 26
POTASSIUM CHLORIDE 358 223 12 9
CARVEDILOL 320 221 13 15
MELOXICAM 315 198 14 13
FAMOTIDINE 304 199 15 64
METFORMIN HCL 295 201 16 8
LISINOPRIL 295 231 16 5
METOPROLOL SUCCINATE 285 209 18 14
PANTOPRAZOLE SODIUM 284 204 19 42
QUETIAPINE FUMARATE 260 196 20 72
WARFARIN SODIUM 253 156 21 18
SIMVASTATIN 246 176 22 6
NORTRIPTYLINE HCL 221 94 23 233
DIOVAN 211 153 24 37
CITALOPRAM HBR 210 182 25 17
TOPIRAMATE 199 69 26 141
ZOLPIDEM TARTRATE 193 96 27 21
DIVALPROEX SODIUM 187 82 28 99
CLOPIDOGREL 182 130 29 28
METOPROLOL TARTRATE 169 121 30 22
MIRTAZAPINE 165 136 31 59
EXELON 162 151 32 130
PLAVIX 158 119 33 40
CYMBALTA 154 78 34 47
ADVAIR DISKUS 153 107 35 87
GLIMEPIRIDE 147 115 36 30
PREDNISONE 146 88 37 53
ATORVASTATIN CALCIUM 144 56 38 20
SEROQUEL 140 115 39 135
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 84 40 16
ISOSORBIDE MONONITRATE ER 130 103 41 54
HYDRALAZINE HCL 130 71 41 77
JANTOVEN 120 82 43 156
ALLOPURINOL 120 102 43 31
LEVOFLOXACIN 111 75 45 91
SPIRONOLACTONE 109 47 46 62
MEGESTROL ACETATE 108 89 R 47 111
CARBIDOPA-LEVODOPA 107 79 48 114
CYCLOBENZAPRINE HCL 104 30 R 49 50
METFORMIN HCL ER 103 89 50 63
TAMSULOSIN HCL 102 90 51 38
TRAMADOL HCL 100 72 52 19
AMITRIPTYLINE HCL 100 26 R 52 46
POLYETHYLENE GLYCOL 3350 99 70 54 56
SINGULAIR 99 80 54 80
NEXIUM 96 52 56 23
BUPROPION HCL SR 94 40 57 212
ESCITALOPRAM OXALATE 93 78 58 73
LOSARTAN POTASSIUM 92 59 59 34
CARISOPRODOL 89 0 R 60 60
VENLAFAXINE HCL ER 89 65 60 98
CELEBREX 89 50 60 108
RANITIDINE HCL 85 79 63 27
ABILIFY 85 20 63 133
FLUTICASONE PROPIONATE 85 56 63 49
PHENYTOIN SODIUM EXTENDED 84 52 66 88
CRESTOR 84 60 66 29
NOVOLOG MIX 70-30 83 61 68 203
HYDROCHLOROTHIAZIDE 82 72 69 12
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 60 69 74
TRIAMTERENE-HCTZ 80 56 71 43
SYNTHROID 78 58 72 48
NITROFURANTOIN MONO-MACRO 77 61 73 182
RISPERIDONE 77 18 73 69
LANTUS 76 59 75 55
LEVETIRACETAM 75 15 76 138
SPIRIVA 75 55 76 97
ENDOCET 74 43 S2 78 104
JANUVIA 74 23 78 78
TRICOR 74 57 78 126
ROPINIROLE HCL 73 56 81 85
AMLODIPINE BESYLATE-BENAZEPRIL 72 53 82 44
JANUMET 72 42 82 167
GEMFIBROZIL 72 47 82 137
BUSPIRONE HCL 71 44 85 113
PRISTIQ ER 70 32 86 288
DIGOXIN 69 42 87 52
FENTANYL 68 50 S2 88 93
DETROL LA 68 21 88 166
MORPHINE SULFATE ER 62 38 S2 90 131
PROMETHAZINE HCL 62 30 R 90 75
NOVOLIN R 62 48 90 153
VOLTAREN 62 49 90 276
FLUCONAZOLE 62 32 90 115
LYRICA 61 20 95 57
FLECTOR 59 52 96 394
KLOR-CON 10 59 33 96 95
SUBOXONE 58 0 98 173
DOXYCYCLINE HYCLATE 58 27 98 82
SOTALOL 58 46 98 221
METOCLOPRAMIDE HCL 57 44 101 107
AZELASTINE HCL 57 31 101 315
LEXAPRO 57 41 101 210
SUCRALFATE 55 48 104 187
SYMBICORT 55 33 104 189
AMIODARONE HCL 54 41 106 154
MONTELUKAST SODIUM 53 41 107 150
DIOVAN HCT 53 32 107 41
DIVALPROEX SODIUM ER 52 43 109 168
OXYBUTYNIN CHLORIDE 50 22 110 149
BENZTROPINE MESYLATE 50 0 R 110 129
LOSARTAN-HYDROCHLOROTHIAZIDE 50 46 110 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.